Would it be easier to get a research license from the FDA?
Congress recently passed the Medical Marijuana and Cannabidiol Research Expansion Act, H.R. 8454, which may have an impact on the availability of cannabis for research purposes. This law aims to advance cannabis research by streamlining DEA’s role and expanding sources of research-grade marijuana. The law mandates DEA to accept applications for registration if approved by applicable agencies FDA or NIH, or if DEA protocols are met. The law also aims to increase commercial production and manufacturers for research. Though it doesn’t solve all access issues, it aims to significantly broaden DEA-registered research sources. That said, some have argued that it makes obtaining a research license harder, not easier, so it may not be clear until the the law in fully implemented.